BackBionoid Pharma Overview

Bionoid Pharma Other Liabilities

Track Bionoid Pharma's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Bionoid Pharma Other Liabilities History

Loading

Bionoid Pharma vs. peers: Other Liabilities Comparison

Loading

Bionoid Pharma Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Bionoid Pharma (BINP) FAQ

The latest other liabilities for BINP is $0 as of September 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Bionoid Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, BINP's other liabilities moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bionoid Pharma's operating scale or balance-sheet position.

A other liabilities figure of $0 for BINP is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BINP's other liabilities ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers